I am glad for you that this is your experience and I agree that often the less positive effects garner more attention. From some of the research I’ve looked at it seems that up about a third of people do at some point stop taking the meds due to side effects which is quite a high attrition rate. I’m currently a participant in a research study Roseta (in UK) which is designed to encourage people to keep on with therapy and also to pinpoint why they drop out. Your point that individual reactions can vary widely is a good reason not to discourage people from beginning therapy. I’m one of the strugglers but hanging on in there.